NLRP3 and neoplasm: Moreover, the potential of NLRP3 inhibitors such as MCC950 and colchicine in suppressing tumor growth has been demonstrated in experimental models of head and neck squamous cell carcinoma and gastric cancer (Chen L. et al., 2018; Zhang T. et al., 2019).